Stilla Technologies

Multiplex 6-Color Digital PCR for high-sensitivity genomic analysis, liquid biopsies, rare event detection, SARS-CoV-2, GMO, food, enviro, & wastewater testing

[Stilla Technologies @StillaTech]

Last week our team unveiled the Nio™+ physically at Oxford Global's NextGen Omics conference in London, UK.

A booth packed with curious people, and a feedback from our early access users at CHU de Rennes.

Couldn't attend live? Watch on-demand here https://t.co/p3kXhLEEJc

[Stilla Technologies @StillaTech]

Our first application note on Nio+, released last Friday, is now available. Get access below:
https://t.co/EGTTpjQDbC

[Stilla Technologies @StillaTech]

It's finally here.

Meet Nio+.

Automation-friendly.
All-in-one.
Continuous loading.
7 colors.
Capacity of 768.

See it here.
https://t.co/cIlTfNmuij

[Stilla Technologies @StillaTech]

We're just hours away from unveiling the next leap in digital PCR. Last chance to register — secure your spot now!

https://t.co/WtWCSL3gHb

[Stilla Technologies @StillaTech]

Meet the team at NextGen Omics 2023 and discover the next leap forward in digital PCR, live.

Can't attend live?

Register via: https://t.co/lB0tL4lrA7

[Stilla Technologies @StillaTech]

Our next product was not created in a vacuum. Listen to the first impressions of innovators across Europe.

Register via https://t.co/paHT9juFBg

[Stilla Technologies @StillaTech]

Next to experts in oncology & digital PCR, our team also gave early access to the team at Exothera.

Learn how they experienced our next product on November 10th, register via https://t.co/2L3QPJZbd6

[Stilla Technologies @StillaTech]

700+ people have registered for us taking the next leap forward in digital PCR. Spanning well over 40 different nationalities across the globe.

Do not miss out & register for our product announcement below:
https://t.co/SSMqNEmwbN

[Stilla Technologies @StillaTech]

Headscratcher. Though not to the trained eye.

Discover all about our next product announcement, register today.
https://t.co/djwzPykDum

[Stilla Technologies @StillaTech]

We're collaborating with Europe's leading digital PCR innovators. These past weeks we've collaborated with digital PCR consortium at the University of Ghent.

Curious to learn more? Hear all about it during our November 10th announcement
https://t.co/c5rdolA4rr

[Stilla Technologies @StillaTech]

We can't w8.

Register to our November product announcement.

https://t.co/zWZJNOiJNe

[Stilla Technologies @StillaTech]

Learn what’s behind #7, register to our product announcement via the link below.

https://t.co/B3NDAhQC4u

[Stilla Technologies @StillaTech]

During our early access programme, we're working with leading institutes in oncology, cell and gene therapy as well as digital PCR technology experts.

Last week: Centre Eugène Marquis in Rennes, France.

Learn about it during our Nov. 10th announcement:
https://t.co/sVvOxz4Ner

[Stilla Technologies @StillaTech]

The next leap forward in digital PCR.

Don't forget to register:

https://t.co/J7MUkY2QUE

[Stilla Technologies @StillaTech]

The next leap forward in digital PCR.

Register to our November 10th product announcement:
https://t.co/IbEzI9caJX

[Stilla Technologies @StillaTech]

Great @biocompare piece on the best uses for dPCR and qPCR. Stilla’s Matthew Grow discusses multiplexed dPCR as a diagnostic complementary to NGS that can allow hospital labs to run more in-house patient testing in place of outsourced or centralized labs: https://t.co/bojAVjMLuv

[Stilla Technologies @StillaTech]

For our second installment of #StillaSpotlight, meet Kimberley Gutierrez, PhD, Business Development, Applications Lead. Kim has her sights set on the future of PCR and is excited to see digital PCR grow more in the clinical market and become a new gold standard.

[Stilla Technologies @StillaTech]

We had a fantastic time at today’s Genomics in Precision Oncology Xchange, where Stilla’s co-founder and Dir. of Business & Corp. Development Clément Gay gave the keynote: “Getting de-centralized testing into routine clinical oncology using high-performance genetic multiplexing.”

[hubXchange @hub_xchange]

Join us & others at our European Genomics in Precision Oncology hybrid roundtable Xchange in Munich, June 28. View agenda & register at https://t.co/jV4uy4pNXv. Open to Senior Scientists in the pharma/biotech industry #Oncology #Genomics #lifesciences #pharmacology #Biotechnology

[Stilla Technologies @StillaTech]

Are you familiar with Limit of Blank (LoB) and Limit of Detection (LoD)? Determining a false-positive cutoff when quantifying nucleic acids is critical to the robustness and reliability of a dPCR assay. Check out our technical note: https://t.co/7CVId0LqHx

[Stilla Technologies @StillaTech]

We’re feeling inspired after participating in the Bioserra LabCluster Tour with other innovative companies including our partner @promega. The Stilla team presented on high-multiplexing #digitalPCR tech in oncology—from clinical research to drug development to patient follow-up.